MedPath
HSA Approval

CLONAZEPAM MEVON TABLETS 0.5 MG

SIN17075P

CLONAZEPAM MEVON TABLETS 0.5 MG

CLONAZEPAM MEVON TABLETS 0.5 MG

September 3, 2024

NOVEM HEALTHCARE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM HEALTHCARE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N03AE01

Manufacturer Information

NOVEM HEALTHCARE PTE LTD

Neuraxpharm Pharmaceuticals, S.L.

Active Ingredients

Clonazepam

0.500 mg

Clonazepam

Documents

Package Inserts

Clonazepam Mevon Tablet PI.pdf

Approved: September 3, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CLONAZEPAM MEVON TABLETS 0.5 MG - HSA Approval | MedPath